Theodore Karrison to Clinical Trials as Topic
This is a "connection" page, showing publications Theodore Karrison has written about Clinical Trials as Topic.
Connection Strength
0.966
-
There Is More to Length of Survival Than Survival: Endpoints in Oncology Trials. Clin Cancer Res. 2024 Aug 01; 30(15):3098-3099.
Score: 0.641
-
Comparison of median survival times with adjustment for covariates. Stat Med. 1995 Dec 15; 14(23):2537-53.
Score: 0.088
-
Effects of vascular endothelial growth factor signaling inhibition on human erythropoiesis. Oncologist. 2013; 18(8):965-70.
Score: 0.075
-
Functional equality of coordinating centers in a multicenter clinical trial. Experience of the International Mexiletine and Placebo Antiarrhythmic Coronary Trial (IMPACT). Control Clin Trials. 1986 Mar; 7(1):38-52.
Score: 0.045
-
Leveraging external control data in the design and analysis of neuro-oncology trials: Pearls and perils. Neuro Oncol. 2024 05 03; 26(5):796-810.
Score: 0.039
-
Data editing in a clinical trial. Control Clin Trials. 1981 May; 2(1):15-29.
Score: 0.032
-
Confidence intervals for median survival times under a piecewise exponential model with proportional hazards covariate effects. Stat Med. 1996 Jan 30; 15(2):171-82.
Score: 0.022
-
A controlled trial of extended radical versus radical mastectomy. Ten-year results. Cancer. 1989 Jan 01; 63(1):188-95.
Score: 0.014
-
A controlled trial of extended radical mastectomy. Cancer. 1985 Feb 15; 55(4):880-91.
Score: 0.010